Gilead Sciences, Inc. (GILD)’s Breast Cancer Study Success Drives Investor Optimism Amid Broader Market Slump

finance.yahoo.com/news/gilead-sciences-inc-gild-breast-150250925.html

In This Article:
Gilead Sciences, Inc. (NASDAQ:GILD) has revealed encouraging results from its ASCENT-03 clinical trial, showcasing a major breakthrough in treating metastatic triple-negative breast cancer (mTNBC). Trodelvy (sacituzumab govitecan-hziy) demonstrated a significant and…

This story appeared on finance.yahoo.com, 2025-05-24 15:02:50.
The Entire Business World on a Single Page. Free to Use →